Inc. Biogen serves as Executive at SANGAMO THERAPEUTICS, INC, where they oversee executive responsibilities. Since joining the company, Inc. Biogen has executed 9 insider transactions totaling $7.7M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 26, 2023 involved selling 6,000,000 shares valued at $3.0M.
Inc. Biogen currently holds 17,652,466 shares of SANGAMO THERAPEUTICS, INC (SGMO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Inc. Biogen has been a net seller of SGMO stock. They have purchased $0 and sold $7.7M worth of shares.
Inc. Biogen's most recent insider trade was on Sep 26, 2023, when they sold 6,000,000 shares at $0.50 per share.
Get notified when new Form 4 filings are submitted
| $5.27 |
| Discretionary |
| Aug 29, 2022 | SGMO | $2.1M | Sale | 400,000 | $5.33 | Discretionary |
| Dec 28, 2021 | SGMO | $23.5K | Sale | 2,764 | $8.51 | Discretionary |
| Dec 27, 2021 | SGMO | $5.1K | Sale | 600 | $8.56 | Discretionary |
| Dec 23, 2021 | SGMO | $694.1K | Sale | 81,187 | $8.55 | Discretionary |
| Dec 9, 2021 | SGMO | $202.5K | Sale | 23,660 | $8.56 | Discretionary |
| Dec 8, 2021 | SGMO | $655.0K | Sale | 75,814 | $8.64 | Discretionary |
| Dec 7, 2021 | SGMO | $444.6K | Sale | 52,178 | $8.52 | Discretionary |